Trials / Withdrawn
WithdrawnNCT00346177
Stem Cell Study for Patients With Heart Failure
Injection of Autologous CD34+ Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia and LVEF < 40%
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Losordo, Douglas, M.D. · Individual
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if cell therapy with your own cells (autologous cells) delivered with a catheter to regions of the heart with poor blood flow will be safe and if it will improve your ejection fraction and heart failure symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous Stem Cells | Intramyocardial injections |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-09-01
- Completion
- 2012-09-01
- First posted
- 2006-06-29
- Last updated
- 2010-09-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00346177. Inclusion in this directory is not an endorsement.